European Archives - Page 1125 of 1367 - European Medical Journal

New Probe Improves the Ability to Predict Heart Attacks

The result of a recent study could change the way in which the vasculature of the heart is investigated. Read the article and find out more

Hypertension is a Biomarker for Dementia Development

WOMEN aged between 40 and 50 years suffering from hypertension have a much greater risk of developing dementia in later life, compared to men of a…

Risk of Obstructive Sleep Apnoea Identified in Menopausal Women

WOMEN who have severe hot flushes in midlife are at a greater risk of obstructive sleep apnoea (OSA) than those who experience mild or no hot flushes…

EMJ

Interview with Almirall Global Marketing Dermatology Director About New Psoriasis Treatment

Members of the EMJ team were delighted to meet Mr Rajesh Gupta, the Global Marketing Dermatology Director of Almirall, S.A. (Barcelona, Spain), for an…

Introducing EMJ Dermatology 5.1

United Kingdom, November 02, 2017: The European Medical Journal welcomes you to the 2017 edition of EMJ Dermatology, complete with a summary of…

New Recommendations for Improving Junior Doctors’ Working Environment

RECOMMENDATIONS for improving the working environment and morale for junior doctors have been published by NHS Improvement in conjunction with the…

Review of the 26th European Academy of Dermatology and Venerology Congress 2017

A review of the 26th European Academy of Dermatology and Venereology (EADV) congress, held from the 13th–17th September 2017

The Associations of Human Leukocyte Antigen Class I and Class II Alleles in Bullous Pemphigoid

Bullous pemphigoid is a complex, multifactorial autoimmune disease characterised by the presence of autoantibodies against BP autoantigens, leading…

Pseudoxanthoma Elasticum

Pseudoxanthoma elasticum (PXE) is an inherited multisystem disorder characterised by pathological calcification of elastic connective tissue.

Innovation That Drives Your Dermatological Future

This symposium is focused on topical therapies in the treatment of psoriasis and the unmet clinical and patient quality of life needs.